• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
  • Contact

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Gardasil Attorneys Allege HPV Vaccine Caused Girl to Develop POTS

Baum Hedlund Aristei & Goldman (PRNewsfoto/Baum Hedlund Aristei & Goldman)

News provided by

Baum Hedlund Aristei & Goldman

Nov 18, 2020, 17:48 ET

Share this article

Share this article


MADISON, Wis., Nov. 18, 2020 /PRNewswire/ -- Gardasil attorneys from the national law firm of Baum Hedlund Aristei & Goldman filed a lawsuit against Merck on behalf of a young woman who alleges she developed Postural Orthostatic Tachycardia (POTS) and a host of other serious injuries after receiving the human papillomavirus (HPV) vaccine.

Continue Reading
Sahara Walker
Sahara Walker

Attorneys Bijan Esfandiari, Nicole K. H. Maldonado, Michael L. Baum, and Robert F. Kennedy, Jr. (co-counsel) filed the Gardasil HPV vaccine lawsuit in U.S. District Court for the Western District of Wisconsin against New Jersey-based Merck & Co. Inc. and its subsidiary Merck Sharp & Dohme.

The plaintiff in the case, Sahara Walker of Lake Mills, Wisconsin, received the Gardasil vaccine when she was just 11 years old. She spent the next five years being severely disabled and unable to attend school or participate in activities she once enjoyed. Though still very disabled at the age of 19, special infusions now keep her out of bed and able to walk and even mountain bike.

The lawsuit (case no. 3:20-cv-01048) includes allegations of negligence, failure to warn, and manufacturing defects, among others. According to the complaint, Merck knew or had reason to know Gardasil is defective and ineffective, but instead of warning consumers about the dangers, the company wrongfully concealed information and further made false statements concerning the safety and efficacy of Gardasil. Ms. Walker is seeking punitive damages against Merck for creating a substantial risk of significant harm to children and patients who were injected with the Gardasil HPV vaccine.

"Merck is using the same development and marketing playbook for Gardasil that it used when it promoted Vioxx as a headache pill knowing it caused heart attacks" says co-counsel Robert F. Kennedy, Jr. "Vioxx killed hundreds of thousands of Americans and Merck paid $7 billion in penalties and damages and agreed to stop falsifying science. Sadly, Merck learned no lessons. Falsifying science, defrauding regulators and injuring and killing its customers is the only business model this company knows.

Merck utilized all the same strategies to sell Gardasil to our children. The company has sickened an entire generation. The list of casualties and grim injuries continues to multiply. This company is beyond shame or redemption."

____________

 "Data suggests Merck presented regulators with false information about the link between HPV and cervical cancer, which helped give them a runway to fast-track this dangerous vaccine over a matter of six months," says attorney Nicole K.H. Maldonado. "Merck to this day has never properly tested Gardasil to ensure it is safe, and now Sahara and countless others are suffering from debilitating injuries. We will hold Merck accountable for the harm the company has caused."

Young Woman Diagnosed with POTS After Receiving Gardasil Shot

Sahara Walker was 11-years-old when she received her first and only shot of Gardasil on September 25, 2013, per her doctor's recommendation. During the same doctor visit, she also received the Tdap vaccine and the meningococcal conjugate vaccine.

Before receiving the HPV vaccine, Sahara had no autoimmune diseases, no autonomic issues, and no orthostasis. A happy, healthy young girl who had just scored in the top 97th percentile of all Wisconsin students in math, Sahara consistently performed well academically, participated in sports, and was active socially with her friends and peers. She was a "mathlete" and had been on the math team for two years, won tournaments and advanced to State, but was not allowed to attend as she missed too many days of school due to her Gardasil side effects.

Sahara's mother, Mrs. Melissa Roglitz-Walker, wanted her daughter to get the Gardasil vaccine after seeing marketing from Merck maintaining that Gardasil was very safe and prevents cancer. She thought she was being a really good, responsible parent.

Two days after receiving the Gardasil shot, Sahara began to experience vomiting and headaches. One week later, on Oct. 3, 2013, she began to experience severe body aches to go along with the vomiting and headaches from the week prior. She soon had fevers and began excessively sleeping, reporting extreme fatigue while awake. She was also dizzy, weak, and pale. Within a month after the shot she was bedridden, and wheel-chair bound if she had to be transported.

As weeks became months, Sahara's symptoms and injuries continued to worsen. She was seen by multiple physicians and specialists to treat her growing list of symptoms, including daily migraines, severe body aches and pain, and cognitive impairments, among other issues. With little to no relief from her symptoms, Sahara was unable to engage in the activities she had enjoyed before receiving the Gardasil vaccine.

In 2015, Sahara went to 54 doctor appointments. A year later, her medication regimen was up to 55 pills per day. Due to her symptoms, Sahara was no longer able to attend school in the same manner she did prior to her Gardasil injection. She was homeschooled through the majority of 6th through 12th grades, mostly bedridden and confined to a wheelchair.

After undergoing testing to assess her post-Gardasil symptoms and adverse events, Sahara was diagnosed with various medical conditions, including Neurocardiogenic Syncope (NCS), Postural Orthostatic Tachycardia (POTS), a form of Orthostatic Intolerance (OI) called Orthostatic Hypotension (OH), Small Fiber Neuropathy, and severe Autoimmune Autonomic Neuropathy.

Today, Sahara takes 14 prescription medications. She also receives a very expensive Intravenous Immune Globulin (IVIG) treatment at home every three weeks through a central line in her chest. If the IVIG treatment ceases to be administered at these regular intervals, she experiences a dramatic decline in her health to the point of becoming severely disabled again.

IVIG is a blood product prepared from the serum of between 1,000 and 15,000 plasma donors per batch that floods Sahara's system with good antibodies to overrule her own bad antibodies that are attacking her own body. When Covid-19 began to ravage the country, some healthcare professionals turned to IVIG as a treatment option, leaving many people with Gardasil vaccine injuries worried about IVIG supplies running low.

"In speaking with other parents of Gardasil-injured children, I can tell you there is a lot of concern regarding a possible IVIG shortage in the near future," says Mrs. Roglitz-Walker. "It would be devastating for my daughter and for anyone with Autoimmune Autonomic Neuropathy, Small Fiber Neuropathy, POTS, dysautonomia, and other neurological conditions who need this treatment just to keep them from being bedridden."

Allegations in Gardasil Vaccine Lawsuit

Sahara Walker seeks to hold Merck accountable for its negligent, reckless, and fraudulent conduct, and for the physical and emotional injuries she sustained after receiving the Gardasil vaccine.

Before Merck brought Gardasil to market, the company negligently designed and conducted clinical trials to prevent the clinical trials from revealing the vaccine's true risks, including autoimmune diseases, the lawsuit alleges. Furthermore, the complaint alleges that Merck knew or should have known that its poorly designed clinical trials and studies were insufficient to test Gardasil's true long-term safety and efficacy.

According to the complaint, Merck also purposely downplayed Gardasil's dangerous and undisclosed ingredients, including:

  • Phenylmethylsulfonyl fluoride (PMSF) – A toxic nerve agent that is not intended for human consumption or injection.
  • Aluminum Hydroxyphosphate Sulfate (AAHS) – A particularly toxic aluminum-containing adjuvant.
  • Polysorbate 80 – An emulsifier that is associated with many health injuries, including, anaphylaxis, infertility, and cardiac arrest.  
  • Borax – A toxic chemical and may have long-term toxic effects.
  • Genetically Modified Yeast – Studies have linked to various auto-immune disorders.

Attorneys representing Sahara Walker further allege that Gardasil contains a secret DNA adjuvant and potentially hazardous ingredient designed to make the vaccine more potent. Merck allegedly used the DNA adjuvant to prolong Gardasil's immunological effects but illegally omitted it from its list of substances and ingredients in the vaccine. 

If Merck had provided adequate and truthful warnings and properly disclosed and disseminated the true risks, limitations, and lack of efficacy associated with Gardasil to medical providers, patients and the public, Ms. Walker's medical providers would never have offered or recommended the Gardasil vaccine, and Ms. Walker would never have suffered the disabling physical and emotional injuries she continues to endure.  

Statements from the Plaintiff and Her Mother

"My injuries from the Gardasil vaccine have stolen so much from me. Before the vaccine, the possibilities for my future were endless. Now, my life is full of accommodations and medical interventions. It's not how any 19-year-old should have to live. 

I want to warn people of the potential for serious adverse reactions and let others who have been hurt know that they are not alone. I'm fighting for all of us." – Sahara Walker 

"We are pro-vaccine. We would have never had Sahara get the Gardasil vaccine if we didn't believe in the importance of vaccines. But since she became sick and disabled within days of getting the shot, we firmly believe her adverse reactions were caused by the Gardasil vaccine. Though rare, adverse reactions to vaccines are very real.

Pharma companies that develop vaccines should not be allowed to police themselves and cherry pick their own data to mislead the FDA and the public about the safety and efficacy of their vaccines. It's imperative that there be more robust checks and balances as well as increased transparency in order for the medical community and the public to make genuinely informed decisions. Only then will be able to truly protect the lives of our children."
 – Melissa Roglitz-Walker

About Baum Hedlund Aristei & Goldman
Baum Hedlund Aristei & Goldman is one of the nation's leading law firms representing individuals harmed by the Gardasil vaccine. The firm has a long track record of success holding pharmaceutical and chemical companies accountable. The firm co-led two of the Roundup cancer trials against Monsanto, obtaining in 2019, a $2 billion verdict on behalf of Alva and Alberta Pilliod, which was the second highest verdict in the nation and the ninth largest in U.S. history.

Our firm wishes to stress that we are not against vaccines. They have the potential to eradicate disease and save millions of lives. We are, however, against intentional efforts to mislead consumers about the safety and effectiveness of a drug or vaccine. Our firm has always fought—and will continue to fight—for the rights of consumers to be fully and honestly informed about risks associated with any drug, vaccine, chemical, medical device, or consumer product. We will work tirelessly to ensure those rights are defended and victims of injustice are compensated for their injuries. Gardasil makes good vaccines look bad.

SOURCE Baum Hedlund Aristei & Goldman

Modal title

Also from this source

Judge Appoints Four Lawyers to Lead Gardasil MDL-Multidistrict Litigation

Judge Appoints Four Lawyers to Lead Gardasil MDL-Multidistrict Litigation


Judicial Panel Consolidates Gardasil Vaccine Lawsuits in Multidistrict Litigation (MDL)

Judicial Panel Consolidates Gardasil Vaccine Lawsuits in Multidistrict Litigation (MDL)

Explore

More news releases in similar topics

  • Legal Issues

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2023 Cision US Inc.